|
The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Enwell Energy PLC - Ukraine-focused oil and gas exploration and production company - Pretax profit slumps to just $655,000 in the six months to June 30 from $16.8 million the year prior as sales slide 86% to $3.4 million from $23.7 million, primarily as a result of the suspension of production early in the period. This followed a decision by the Ukrainian authorities to suspend the MEX-GOL, SV and VAS production licences for a period of ten years, and consequently all work at these licences is currently suspended. The group is continuing to pursue legal proceedings to challenge the suspension orders, including investigating the possibility of seeking further interim measures to allow restoration of its operations. The group’s limited development programme for the remainder of 2025 and 2026 is expected to be funded from its existing cash resources and operational cash flow, it adds. ---------- Avacta Group PLC - Wetherby, West Yorkshire-based life sciences company - Pretax loss balloons to £16.9 million in the six months to June 30 from £5.7 million the year prior. Last year’s figure includes £13.4 million benefit from revaluation of derivative compared to £1.0 million this time. Revenue is flat at £56,000. Period end cash and cash-equivalent balances are £12.7 million compared to £28.6 million a year ago. ‘We anticipate multiple pipeline updates in the last quarter of 2025, including the data from the first expansion cohort (salivary gland cancer) in the faridoxorubicin program. We look forward to continuing to update on our progress across our programs and exploiting our unique technology,’ company says. ---------- Beacon Energy PLC - Douglas, Isle of Man-based oil and gas mining company - Net loss before tax and finance costs narrows to $444,000 in the six months to June 30 from $2.6 million the year prior. No income is reported, unchanged year-on-year. Beacon Energy says it is in the final stages of agreeing the acquisition of an interest in an onshore gas development asset located in Europe. Believes it has identified a ‘compelling, value accretive opportunity’. Explains that the proposed eal will constitute a reverse takeover. ---------- Cizzle Biotechnology Holdings PLC - London-based life sciences company engaged in developing a blood test for the early detection of the different forms of lung cancer - Operating loss before tax is £381,000 in the six months to June 30, trimmed from £1.4 million the year prior. No revenue is reported, unchanged year-on-year but bottom line benefits from absence of charge for net fair value loss on financial assets compared to £1.1 million the year prior which sees total administrative expenses fall to £382,000 from £1.5 million. ---------- Switch Metals PLC - mining exploration company focused on developing battery and technology metals mines in Ivory Coast - Pretax loss stretches to £1.0 million in the six months to June 30 from £175,877 in the six months to July 31, 2024. Reflects jump in administrative expenses to £896,679 from £175,877 and finance costs of £104,808 compared to nil a year ago. ‘Our objective remains to become a near term cash flow generating junior miner of critical metals,’ says Chief Executive Karl Akueson. ---------- Hemogenyx Pharmaceuticals PLC - London-headquartered biopharmaceutical company focused on treatments for blood diseases - Pretax loss balloons to £5.0 million in the six months to June 30 from £2.8 million the year prior. No revenue is reported, unchanged year-on-year, but bottom line suffers from £2.2 million foreign exchange loss compared to £118,520 gain the year before. ‘The first half of 2025 has been one of steady and meaningful progress. Our principal focus remains the clinical development of HG-CT-1, our fms-like tyrosine kinase 3 targeted autologous CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukaemia,’ company says. ‘Alongside advancing this programme, we have recently strengthened our operational and manufacturing foundations while reducing our operating costs, secured grant and financing support, and positioned the company for potential early revenue generation under an innovative regulatory framework,’ it adds. Enters the second half of 2025 with ‘momentum and with confidence.’ ---------- GenIP PLC - London-based generative AI services provider - Pretax loss stretches to $565,585 in the six months to June 30 from $67,374 the year prior, despite revenue rising to $125,166 from just $18,207. Bottom line is hurt by soaring administrative expenses which jump to $694,250 from $72,210. ‘GenIP’s first half of 2025 has been a period of significant strategic progress, marked by international expansion, significant new client wins, and the launch of services shaped directly by market demand. We secured contracts across new markets including Saudi Arabia, Singapore, Brazil, and Chile, giving us a footprint in 25 countries globally,’ company says. Notes outstanding order book of $813,000 as at June 30. Enters the second half of 2025 in a ‘position of strength’ and confident of delivering sustained growth and long-term value creation for shareholders. GenIP expects to drive revenue growth through new product launches, increased order closures, and accelerated deliveries. Some of the larger orders secured in the early part of the year are scheduled for fulfilment by the end of the financial year, increasing second half revenues beyond that of the first half, it says. ---------- Tan Delta Systems PLC - provider of oil-quality monitoring and maintenance systems for commercial and industrial equipment - Pretax loss widens to £784,941 in the six months to June 30 from £529,562 the year prior, as revenue drops to £526,005 from £657,425. Sales fall reflects the conversion of trial-to-rollout taking longer than anticipated, while widened losses are due to higher administrative costs driven by extensive trial and customer evaluation activities, Tan Delta explains. Expects full year revenue to be not less than £1.0 million. Chief Executive Chris Greenwood says: ‘In general, adoption of our solutions by customers is taking considerably longer than expected resulting in disappointing financial results during the period. However, over the year a great deal of progress has been made developing both existing and new prospects with no shortage of interest from customers to pro-actively engage with us.’ He notes Tan Delta ends the period with no debt, £2.0 million of cash, 216 distributors, 17 active trials and visible forward sales opportunities worth around £64.0 million. ‘Whilst I recognise and apologise for the frustration of the slow financial progress operational activity and prospects are stronger than ever boding well for the future,’ the CEO adds. ---------- Clean Power Hydrogen PLC - Doncaster, Yorkshire-based green hydrogen technology and manufacturing company - Pretax loss widens to £3.7 million in the six months to June 30 from £2.7 million the year prior. Revenue totals just £4,000 compared to nil a year ago. Bottom line is hit by £655,000 onerous contract losses compared to nil a year ago, and an increase in administrative expenses to £3.0 million from £2.8 million. ‘Our focus is now firmly on achieving clear, targeted commercial milestones including executing our growing order book and achieving meaningful revenue,’ company says. The development and commercial launch of the next generation 1MW MFE220 system which is on target to complete within the next 12 months, ‘represents the next major step in our journey, generating first revenues and validating the commercial performance of our 1MW commercial product’, Clean Power Hydrogen comments. ---------- Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
